Export of Health Care Products in China: Current Status and Countermeasures

Export of Health Care Products in China: Current Status and Countermeasures

Xia Xing, Liu Yue, Dong Weitian, Zhao Xiaoyu, Liu Yunfan, Dong Li*

School?of?Business?Administration,?Shenyang?Pharmaceutical?University,?Shenyang?110016,?China

Online:2018-12-20 Published:2018-12-20
Contact: Dong Li, master’s tutor. Major research area: pharmaceutical intellectual property, pharmaceutical international trade research. Tel: 024-23986543, E-mail: sydongli@163.com.

Abstract

Xia Xing, Liu Yue, Dong Weitian, Zhao Xiaoyu, Liu Yunfan, Dong Li. Export of Health Care Products in China: Current Status and Countermeasures[J]. Asina Journal Of Social Pharmacy.

Trendmd

[1]	Qiao Jiahui, Song Yu, Gong Jingran, Chen Yuwen. Research on the Threshold Effect of China’s Pharmaceutical Export Trade on Internal and External R&D Investment [J]. Asian Journal of Social Pharmacy, 2024, 19(2): 135-146.
[2]	Zhang Zongjie, Wu Zhiang. Research on the Countermeasures for the Development of Biopharmaceutical Industrial Parks in China [J]. Asian Journal of Social Pharmacy, 2023, 18(3): 232-238.
[3]	Liu Tianchi, Zeng Yu. SWOT Analysis and Countermeasures Study on TCM Industry in Hainan Free Trade Port [J]. Asian Journal of Social Pharmacy, 2021, 16(1): 41-47.
[4]	Qiao Jiahui, Wang Su, Chen Yuwen. Research on the Relationship between Export Orientation and R&D Investment of China’s Pharmaceutical Industry in Different Regions [J]. Asian Journal of Social Pharmacy, 2021, 16(1): 48-59.
[5]	Kong Deqiang, Dong Li. Analysis of the Current Situation of Active Pharmaceutical Ingredient (API) Export in China [J]. Asian Journal of Social Pharmacy, 2019, 14(3): 126-134.
[6]	Xia Xing, Qin Min, Zhang Cui, Wang Fang, Hong Jiawei, Dong Li. Import of Health care Products in China: Current Status and Countermeasures [J]. Asina Journal Of Social Pharmacy, 2019, 14(1): 21-25.
[7]	QIAN Yun-xu;ZHANG Zhong-peng;YANG Yue;BI Kai-shun. International Trade Status of Chinese Medicinal Materialsfrom 2000 to 2012 [J]. , 2014, 9(3): 115-118.
[8]	ZHANG Zhi-dong;SUN Li-hua. Chinese Herbal Medicine Exports: Existing Problems and Reflections [J]. , 2014, 9(2): 56-59.
[9]	WENG Xin-yu;CHEN Yu-wen;BI Kai-shun. A Study of the Directive 2011/62/EU [J]. , 2013, 8(4): 232-236.
[10]	GE Tian-tong;SUN Li-hua. Import and Export Situation of Chinese Traditional Patent Medicines [J]. , 2013, 8(4): 268-272.
[11]	LUO Lie;YANG Yue;HE Chun-hong. The Influence of EU Technical Barriers on the Export of Chinese Traditional Patent Medicine [J]. , 2012, 7(1): 22-27.
[12]	GAO Jing-mei;DONG Li;SUN Yuan-peng;LIU Juan;TANG Ya-jun. Patent Risk Analysis of China’s Pharmaceutical Export Enterprises [J]. , 2011, 6(3): 141-144.
[13]	HUI Fei;ZHANG Fang. Analysis and Suggestion on China’s TCM Exports [J]. , 2011, 6(3): 145-150.
[14]	GUO Ying;SONG Cheng-yun . Strategies for Active Pharmaceutical Ingredients (API) from China into US Market [J]. , 2010, 5(1): 23-27.
[15]	TANG Ya-jun;DONG Li;LIANG Jin-yu. A Study of TBT Chinese Medical Products Encounter [J]. , 2009, 4(4): 180-185.

Asian Journal Of Social Pharmacy

Export of Health Care Products in China: Current Status and Countermeasures

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments